Calcium Dobesilate Prevents Diabetic Kidney Disease by Decreasing Bim and Inhibiting Apoptosis of Renal Proximal Tubular Epithelial Cells

DNA Cell Biol. 2017 Apr;36(4):249-255. doi: 10.1089/dna.2016.3276. Epub 2017 Feb 2.

Abstract

Apoptosis of renal proximal tubular epithelial cells (PTECs) plays a vital role in the pathogenesis and progression of diabetic kidney disease (DKD). Calcium dobesilate is a vascular protective compound used for treatment of diabetic retinopathy and chronic venous insufficiency. The aim of this study was to determine whether calcium dobesilate can protect PTECs from glucose-induced apoptosis and the potential mechanism of this effect. It is indicated that high glucose promoted abnormal apoptosis of HK2 cells, which was inhibited by treatment of calcium dobesilate, while Bim expression decreased in response to calcium dobesilate in high-glucose-treated HK2 cells. These findings confirmed the therapeutic effects of calcium dobesilate on DKD and emphasized the importance of it as a potentially crucial drug in treatment of DKD.

Keywords: Bim; apoptosis; diabetic kidney disease; proximal tubular epithelial cells.

MeSH terms

  • Apoptosis*
  • Bcl-2-Like Protein 11 / metabolism*
  • Calcium Dobesilate / pharmacology*
  • Calcium Dobesilate / therapeutic use
  • Cell Line
  • Diabetic Nephropathies / prevention & control
  • Epithelial Cells / drug effects
  • Glucose / pharmacology
  • Humans
  • Kidney Tubules, Proximal / cytology
  • Kidney Tubules, Proximal / drug effects*

Substances

  • Bcl-2-Like Protein 11
  • Calcium Dobesilate
  • Glucose